Richard Zarbo, MD, FCAP, comments on the current patient tissue sample process. Dr. Zarbo suggests the current process needs serious revision. “The new process should become seamless, as automated as possible, and with built-in quality control checks,” says Dr. Zarbo. “This will require innovation of technology to continue to provide a substrate for tissue -based pathologic interpretation. This will also require definition of a standardized human interaction with that technology to minimize human error in the new process.”
For the full article click here: How Can Pathology Labs Better Protect Patient Safety? | Zipe-education